Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.45 AUD | -2.84% | -3.86% | +73.12% |
Jun. 06 | Telix Pharmaceuticals Launches $200 Million IPO in US | MT |
Jun. 06 | Telix Pharmaceuticals Launches $200 Million US IPO | MT |
Sales 2024 * | 744M 491M | Sales 2025 * | 940M 620M | Capitalization | 6.13B 4.04B |
---|---|---|---|---|---|
Net income 2024 * | 62M 40.87M | Net income 2025 * | 104M 68.55M | EV / Sales 2024 * | 8.09 x |
Net cash position 2024 * | 108M 70.98M | Net cash position 2025 * | 200M 132M | EV / Sales 2025 * | 6.3 x |
P/E ratio 2024 * |
95.6
x | P/E ratio 2025 * |
54.7
x | Employees | 423 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 60.38% |
Latest transcript on Telix Pharmaceuticals Limited
1 day | -2.84% | ||
1 week | -3.86% | ||
Current month | -3.86% | ||
1 month | +13.68% | ||
3 months | +49.15% | ||
6 months | +85.64% | ||
Current year | +73.12% |
Managers | Title | Age | Since |
---|---|---|---|
Andreas Kluge
FOU | Founder | - | 15-10-31 |
Founder | 49 | 15-10-31 | |
Darren Smith
DFI | Director of Finance/CFO | 58 | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Harry McCann
CHM | Chairman | 83 | 17-09-16 |
Founder | 49 | 15-10-31 | |
Mark Nelson
BRD | Director/Board Member | 64 | 17-09-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.39% | 15 M€ | -3.61% | ||
0.04% | 775 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 17.45 | -2.84% | 1,358,131 |
24-06-06 | 17.96 | +0.39% | 1,822,999 |
24-06-05 | 17.89 | +0.51% | 925,725 |
24-06-04 | 17.8 | -2.47% | 2,150,666 |
24-06-03 | 18.25 | +0.55% | 1,620,346 |
Delayed Quote Australian S.E., June 07, 2024 at 02:11 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+73.12% | 4.03B | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- TLX Stock